Transfusion thresholds in high-risk patients after hip surgery [1]

New England Journal of Medicine

Volumn 366, Issue 13, 2012, Pages 1253-1255

  Houston, Donald S ^a   Zarychanski, Ryan ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; HEMOGLOBIN;

ANEMIA; BLEEDING; BLOOD TRANSFUSION; DISEASE COURSE; FLUID RESUSCITATION; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HIP FRACTURE; HIP SURGERY; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; CLINICAL EFFECTIVENESS; SAMPLE SIZE; WALKING DIFFICULTY; ERYTHROCYTE TRANSFUSION; FEMALE; MALE; NOTE;

ERYTHROCYTE TRANSFUSION; FEMALE; HIP FRACTURES; HUMANS; MALE;

EID: 84859078864     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1201459     Document Type: Letter

References (5)

1. Carson JL, Terrin ML, Noveck H, et al. Liberal orrestrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-62.
2. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999;340:409-17. [Erratum, N Engl J Med 1999;340:1056.] (Pubitemid 29084771)
3. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 2007;369:381-8. (Pubitemid 46188479)
4. Bohlius J, Schmidlin K, Brillant C, et al. Erythropoietin ordarbepoetin for patients with cancer - meta-analysis based on individual patient data. Cochrane Database Syst Rev 2009;3: CD007303.
5. Zarychanski R, Houston DS. Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ 2008;179:333-7. [Erratum, CMAJ 2008;179:449.]